Our preliminary analysis has revealed key insights about HILLEMAN LABORATORIES SINGAPORE PTE. LTD.'s performance and market presence. Here‘s a summary of our findings:
86901
Medical laboratories (e.g. blood analysis laboratories)
SETTING UP LABORATORIES FOR RESEARCH & DEVELOPMENT OF VACCINES & BIOLOGICS
Recently transacted with HILLEMAN LABORATORIES SINGAPORE PTE. LTD.?
How would you rate your overall satisfaction?
Be a part of the community and help others make informed decisions by sharing your experience. Your feedback not only helps the business improve but also assists other customers in choosing the best services and products available.
This is only a preview of the TrustScore results for HILLEMAN LABORATORIES SINGAPORE PTE. LTD., showcasing a few facets of its business that we have analysed.
Established Stage
A established brand is one that has achieved a strong, recognisable presence in its market or industry. These brands are well-known, trusted and often considered as key brands in their space. They have a significant loyal customer base, a clear and consistent identity, and a proven track record of success and growth.
The company's address is not in use by other companies, providing a unique and credible business location. HILLEMAN LABORATORIES SINGAPORE PTE. LTD. is relatively new, having been operational for less than a year. Companies that have been established for a longer period of time are generally considered more reliable and trustworthy.
HILLEMAN LABORATORIES SINGAPORE PTE. LTD. has no presence on career platforms and provides no public information about its work environment or employee satisfaction. This lack of transparency may indicate less focus on employee well-being or difficulty in attracting talent, potentially impacting HILLEMAN LABORATORIES SINGAPORE PTE. LTD.'s long-term success.
The company is not blacklisted by CaseTrust, which is a positive indicator of its credibility. The company is not on the MAS Enforcement List, which is a positive indicator of its compliance with financial regulations.
HILLEMAN LABORATORIES SINGAPORE PTE. LTD. may not have accessible contact information online, which dilutes engagement and credibility. The company has no official business profile on major search engines. This absence makes it difficult for potential customers to verify the company's legitimacy or get in touch, potentially raising suspicions about its credibility.
Sign in to view the analysis and detailed metrics for HILLEMAN LABORATORIES SINGAPORE PTE. LTD.
Sign In to ContinueA large-scale manufacturing facility that develops affordable vaccines in Singapore for common diseases and can easily switch to production of new vaccines for the next pandemic, was officially opened on Wednesday. The $27 million facility is part of a five-year $80 million investment by Hilleman Laboratories, which also includes a research and development (R&D) laboratory in Biopolis. The new 30,000 sq ft manufacturing facility in Depot Road, called Aces, focuses on early clinical development of vaccines during normal time.
9 November 2023
Merck and Wellcome Trust’s Hilleman Laboratories on Monday unveiled a pilot manufacturing facility for vaccine development in Singapore. Comprising an R&D center and a clinical-stage factory, the new production and development hub will support Hilleman’s mission to create affordable biologics and vaccines for Singapore as well as low- and middle-income countries. It will also equip the country with manufacturing firepower to help tackle future pandemics, Hilleman said in a release. The company will lay out 80 million Singapore dollars ($58 million) over the next five years to boost operations, infrastructure and capacity at the site. Hilleman also says it will recruit up to 50 scientists, engineers and managers in the country.
6 December 2021
Have questions? We’re here to help you.
Scam.SG's TrustScore is an AI-driven engine that evaluates a business's trustworthiness by analysing data such as customer feedback, behavioral patterns, and compliance records. This comprehensive assessment results in a numerical score reflecting the entity's reliability.